Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 2
1955 1
1957 2
1958 3
1960 4
1961 3
1963 2
1964 4
1965 3
1966 2
1967 4
1968 2
1969 1
1970 6
1971 1
1972 9
1973 3
1974 4
1975 3
1976 4
1977 1
1978 1
1980 1
1981 1
1983 1
1984 1
1985 1
1986 2
1988 1
1990 1
1991 1
1992 2
1993 2
1996 1
1998 3
1999 5
2000 10
2002 1
2004 3
2005 1
2010 1
2013 1
2014 1
2015 5
2016 6
2017 8
2018 4
2019 7
2020 3
2021 9
2022 6
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Akuthota P, Jayne D, Khoury P, Klion A, Langford CA, Merkel PA, Moosig F, Specks U, Cid MC, Luqmani R, Brown J, Mallett S, Philipson R, Yancey SW, Steinfeld J, Weller PF, Gleich GJ; EGPA Mepolizumab Study Team. Wechsler ME, et al. Among authors: steinfeld j. N Engl J Med. 2017 May 18;376(20):1921-1932. doi: 10.1056/NEJMoa1702079. N Engl J Med. 2017. PMID: 28514601 Free PMC article. Clinical Trial.
BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.
Zhao W, Steinfeld JB, Liang F, Chen X, Maranon DG, Jian Ma C, Kwon Y, Rao T, Wang W, Sheng C, Song X, Deng Y, Jimenez-Sainz J, Lu L, Jensen RB, Xiong Y, Kupfer GM, Wiese C, Greene EC, Sung P. Zhao W, et al. Among authors: steinfeld jb. Nature. 2017 Oct 19;550(7676):360-365. doi: 10.1038/nature24060. Epub 2017 Oct 4. Nature. 2017. PMID: 28976962 Free PMC article.
HES and EGPA: Two Sides of the Same Coin.
Khoury P, Akuthota P, Kwon N, Steinfeld J, Roufosse F. Khoury P, et al. Among authors: steinfeld j. Mayo Clin Proc. 2023 Jul;98(7):1054-1070. doi: 10.1016/j.mayocp.2023.02.013. Mayo Clin Proc. 2023. PMID: 37419574 Free article. Review.
Reply.
Wechsler ME, Pouliquen I, Steinfeld J, Bradford ES; MIRRA study team. Wechsler ME, et al. Among authors: steinfeld j. J Allergy Clin Immunol. 2019 Aug;144(2):622. doi: 10.1016/j.jaci.2019.03.031. Epub 2019 May 2. J Allergy Clin Immunol. 2019. PMID: 31056189 No abstract available.
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.
Roufosse F, Kahn JE, Rothenberg ME, Wardlaw AJ, Klion AD, Kirby SY, Gilson MJ, Bentley JH, Bradford ES, Yancey SW, Steinfeld J, Gleich GJ; HES Mepolizumab study group. Roufosse F, et al. Among authors: steinfeld j. J Allergy Clin Immunol. 2020 Dec;146(6):1397-1405. doi: 10.1016/j.jaci.2020.08.037. Epub 2020 Sep 18. J Allergy Clin Immunol. 2020. PMID: 32956756 Free PMC article. Clinical Trial.
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.
Steinfeld J, Bradford ES, Brown J, Mallett S, Yancey SW, Akuthota P, Cid MC, Gleich GJ, Jayne D, Khoury P, Langford CA, Merkel PA, Moosig F, Specks U, Weller PF, Wechsler ME. Steinfeld J, et al. J Allergy Clin Immunol. 2019 Jun;143(6):2170-2177. doi: 10.1016/j.jaci.2018.11.041. Epub 2018 Dec 19. J Allergy Clin Immunol. 2019. PMID: 30578883 Free PMC article. Clinical Trial.
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype.
Terrier B, Jayne DRW, Hellmich B, Bentley JH, Steinfeld J, Yancey SW, Kwon N, Akuthota P, Khoury P, Baylis L, Wechsler ME; EGPA mepolizumab study team. Terrier B, et al. Among authors: steinfeld j. ACR Open Rheumatol. 2023 Jul;5(7):354-363. doi: 10.1002/acr2.11571. Epub 2023 Jun 13. ACR Open Rheumatol. 2023. PMID: 37312233 Free PMC article.
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5.
Rothenberg ME, Roufosse F, Faguer S, Gleich GJ, Steinfeld J, Yancey SW, Mavropoulou E, Kwon N; HES Mepolizumab Study Group. Rothenberg ME, et al. Among authors: steinfeld j. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2367-2374.e3. doi: 10.1016/j.jaip.2022.04.037. Epub 2022 May 12. J Allergy Clin Immunol Pract. 2022. PMID: 35568330 Free article. Clinical Trial.
153 results